Blog Read the latest perspectives from our team of subject matter experts and others Ribbon Health and H1: Merging Missions to Transform HealthcareOn January 8th, we celebrated an exciting milestone: Ribbon Health merged with H1! This union represents a significant leap toward achieving our shared vision of transforming healthcare by ensuring… Continue reading → Read the article Post Topics:Artificial Intelligence Commercialization Diversity & Inclusion Drug Development Global Impact HCP Volunteers KOL Engagement Provider Data Research Post Industries:Commercialization Global Impact Payors Pharmaceutical & Biotechnology Provider Data Research KOL EngagementHelpful Hints for MSLsBeginning a new job is exciting, even though new jobs often come with new obstacles and potential challenges. Through the duration of the application process, the prospect of being a… Continue reading → Read the article CommercializationDiversity & InclusionDrug DevelopmentKOL EngagementProvider DataResearchH1 Closes $58 Million Series B FundingToday, H1 announced a $58 million Series B round of funding to continue working towards our mission of creating a healthier future by connecting parties in the healthcare ecosystem.… Continue reading → Read the article KOL EngagementComplying with MSL RegulationsMedical Science Liaisons (MSLs) are members of the Medical Affairs departments in pharmaceutical companies and have a wide range of responsibilities. An important part of the MSL role is… Continue reading → Read the article KOL EngagementMSL Conduct Dos and Don’tsMedical Science Liaisons (MSLs) are in the field (almost) every day and so are their field-based commercial colleagues, specifically sales representatives. Although they interact with the same people, healthcare… Continue reading → Read the article KOL EngagementPayor Mix: Understanding How Patients Receive Care and Who Pays for itTo find out which healthcare providers (HCPs) are actively treating patients in a therapeutic area, you’ll want access to more than just publication information. To really dig in, you… Continue reading → Read the article KOL EngagementAnnouncing A New Way to Identify KOLs with Claims DataPublications can only get you so far. If your medical affairs team really wants to know who’s actively treating patients in a therapeutic area, you need access to claims data.… Continue reading → Read the article«‹12131415161718›»